Literature DB >> 26315715

Rheumatologist and Primary Care Management of Cardiovascular Disease Risk in Rheumatoid Arthritis: Patient and Provider Perspectives.

Christie M Bartels1, Tonya J Roberts1, Karen E Hansen1, Elizabeth A Jacobs1, Andrea Gilmore1, Courtney Maxcy1, Barbara J Bowers1.   

Abstract

OBJECTIVE: Despite increased cardiovascular disease (CVD) risk, rheumatoid arthritis (RA) patients often lack CVD preventive care. We examined CVD preventive care processes from RA patient and provider perspectives to develop a process map for identifying targets for future interventions to improve CVD preventive care.
METHODS: Thirty-one participants (15 patients, 7 rheumatologists, and 9 primary care physicians [PCPs]) participated in interviews that were coded using NVivo software and analyzed using grounded theory techniques.
RESULTS: Patients and providers reported that receipt of preventive care depends upon identifying and acting on risk factors, although most noted that both processes rarely occurred. Engagement in these processes was influenced by various provider-, system-, visit-, and patient-related conditions, such as patient activation or patients' knowledge about their risk. While nearly half of patients and PCPs were unaware of RA-CVD risk, all rheumatologists were aware of risk. Rheumatologists reported not systematically identifying risk factors, or, if identified, they described communicating about CVD risk factors via clinic notes to PCPs instead of acting directly due to perceived role boundaries. PCPs suggested that scheduling PCP visits could improve CVD risk management, and all participants viewed comanagement positively.
CONCLUSION: Findings from this study illustrate important gaps and opportunities to support identifying and acting on CVD risk factors in RA patients from the provider, system, visit, and patient levels. Future work should investigate professional role support through improved guidelines, patient activation, and system-based RA-CVD preventive care strategies.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Year:  2016        PMID: 26315715      PMCID: PMC4893805          DOI: 10.1002/acr.22689

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  33 in total

1.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Authors:  M J L Peters; D P M Symmons; D McCarey; B A C Dijkmans; P Nicola; T K Kvien; I B McInnes; H Haentzschel; M A Gonzalez-Gay; S Provan; A Semb; P Sidiropoulos; G Kitas; Y M Smulders; M Soubrier; Z Szekanecz; N Sattar; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2009-09-22       Impact factor: 19.103

2.  Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis.

Authors:  Christie M Bartels; Amy J H Kind; Carolyn T Thorpe; Christine M Everett; Rachel J Cook; Patrick E McBride; Maureen A Smith
Journal:  Semin Arthritis Rheum       Date:  2012-03-16       Impact factor: 5.532

3.  Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Maher R Khdour; Ahmed F Hawwa; Joseph C Kidney; Bronagh M Smyth; James C McElnay
Journal:  Eur J Clin Pharmacol       Date:  2012-04-05       Impact factor: 2.953

4.  Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations.

Authors:  Jette Primdahl; Joan Clausen; Kim Hørslev-Petersen
Journal:  Ann Rheum Dis       Date:  2013-07-12       Impact factor: 19.103

5.  Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center.

Authors:  Stephanie O Keeling; Michelle Teo; Daisy Fung
Journal:  Clin Rheumatol       Date:  2011-04-19       Impact factor: 2.980

6.  Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis.

Authors:  Christie M Bartels; Amy J H Kind; Christine Everett; Matthew Mell; Patrick McBride; Maureen Smith
Journal:  Arthritis Rheum       Date:  2011-05

7.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

8.  Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis.

Authors:  Tracy U Nguyen-Oghalai; Sonya E Hunnicutt; Sarah Toombs Smith; Rashmi Maganti; Terry A McNearney
Journal:  J Clin Rheumatol       Date:  2007-12       Impact factor: 3.517

9.  Improved blood pressure control associated with a large-scale hypertension program.

Authors:  Marc G Jaffe; Grace A Lee; Joseph D Young; Stephen Sidney; Alan S Go
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

10.  Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s.

Authors:  N Goodson; J Marks; M Lunt; D Symmons
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

View more
  22 in total

1.  Rheumatologists Modestly More Likely to Counsel Smokers in Visits Without Rheumatoid Arthritis Control: An Observational Study.

Authors:  Andrew P Vreede; Heather M Johnson; Megan Piper; Daniel J Panyard; Joanna C Wong; Christie M Bartels
Journal:  J Clin Rheumatol       Date:  2017-08       Impact factor: 3.517

2.  Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.

Authors:  Iris Navarro-Millán; Parag Goyal; Monika M Safford
Journal:  Rheumatology (Oxford)       Date:  2019-06-01       Impact factor: 7.580

3.  Patient Perspectives on Smoking Cessation and Interventions in Rheumatology Clinics.

Authors:  Aimée Wattiaux; Brittany Bettendorf; Laura Block; Andrea Gilmore-Bykovskyi; Edmond Ramly; Megan E Piper; Ann Rosenthal; Jane Sadusky; Elizabeth Cox; Betty Chewning; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

Review 4.  Managing premature atherosclerosis in patients with chronic inflammatory diseases.

Authors:  Alexandra Legge; John G Hanly
Journal:  CMAJ       Date:  2018-04-09       Impact factor: 8.262

5.  Screening of Hyperlipidemia Among Patients With Rheumatoid Arthritis in the United States.

Authors:  Iris Navarro-Millán; Shuo Yang; Lang Chen; Huifeng Yun; Aprajita Jagpal; Christie M Bartels; Liana Fraenkel; Monika M Safford; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-12       Impact factor: 4.794

Review 6.  Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches.

Authors:  Ann M Chodara; Aimée Wattiaux; Christie M Bartels
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

7.  Frequency and Predictors of Communication About High Blood Pressure in Rheumatoid Arthritis Visits.

Authors:  Christie Michels Bartels; Heather Johnson; Katya Alcaraz Voelker; Alexis Ogdie; Patrick McBride; Elizabeth A Jacobs; Ying-Qi Zhao; Maureen Smith
Journal:  J Clin Rheumatol       Date:  2018-06       Impact factor: 3.517

8.  Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.

Authors:  Kashif Jafri; Christie M Bartels; Daniel Shin; Joel M Gelfand; Alexis Ogdie
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11-28       Impact factor: 4.794

9.  Expect delays: poor connections between rural and urban health systems challenge multidisciplinary care for rural Americans with diabetic foot ulcers.

Authors:  Bryn L Sutherland; Kristen Pecanac; Christie M Bartels; Meghan B Brennan
Journal:  J Foot Ankle Res       Date:  2020-06-16       Impact factor: 2.303

10.  Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use.

Authors:  Nancy Crego; Christian Douglas; Emily Bonnabeau; Marian Earls; Kern Eason; Elizabeth Merwin; Gary Rains; Paula Tanabe; Nirmish Shah
Journal:  J Am Board Fam Med       Date:  2020 Jan-Feb       Impact factor: 2.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.